Literature DB >> 11959186

Clinical management of renal transplant patients with hepatitis C virus infection treated with cyclosporine or tacrolimus.

A Latorre1, E Morales, E Gonzalez, J C Herrero, M Ortiz, P Sierra, B Dominguez-Gil, A Torres, M A Munoz, A Andres, C Manzanares, J M Morales.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11959186     DOI： 10.1016/s0041-1345(01)02678-1

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  3 in total

1.  Impact of direct-acting antivirals for hepatitis C virus therapy on tacrolimus dosing in liver transplant recipients.

Authors:  Alexandra L Bixby; Linda Fitzgerald; Rachael Leek; Jessica Mellinger; Pratima Sharma; Sarah Tischer
Journal:  Transpl Infect Dis       Date:  2019-04-01       Impact factor: 2.228

2.  Influence of chronic hepatitis C infection on cytochrome P450 3A4 activity using midazolam as an in vivo probe substrate.

Authors:  P N Morcos; S A Moreira; B J Brennan; S Blotner; N S Shulman; P F Smith
Journal:  Eur J Clin Pharmacol       Date:  2013-06-14       Impact factor: 2.953

3.  Impact of Inflammation on Cytochromes P450 Activity in Pediatrics: A Systematic Review.

Authors:  Camille Lenoir; Frédérique Rodieux; Jules A Desmeules; Victoria Rollason; Caroline F Samer
Journal:  Clin Pharmacokinet       Date:  2021-08-31       Impact factor: 6.447
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.